MAPK8 and Miyoshi myopathy: Addition of JNK-IN-8 enhanced cell viability compared to ixazomib in combination with only BAF (Fig. 6B), thereby confirming that JNK is an important mediator in cell apoptosis induced by combination treatment in MM cells.